ATE122352T1 - 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen. - Google Patents

3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.

Info

Publication number
ATE122352T1
ATE122352T1 AT89313491T AT89313491T ATE122352T1 AT E122352 T1 ATE122352 T1 AT E122352T1 AT 89313491 T AT89313491 T AT 89313491T AT 89313491 T AT89313491 T AT 89313491T AT E122352 T1 ATE122352 T1 AT E122352T1
Authority
AT
Austria
Prior art keywords
azabicycloheptan
oxadiazole
ethyl
production
pharmaceutical preparations
Prior art date
Application number
AT89313491T
Other languages
English (en)
Inventor
Michael Stewart Beecham Hadley
Centre Coldharbour Ro Research
Paul Adrian Beecham Phar Wyman
Barry Sidney Beecham Pha Orlek
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Application granted granted Critical
Publication of ATE122352T1 publication Critical patent/ATE122352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
AT89313491T 1988-12-23 1989-12-21 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen. ATE122352T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888830226A GB8830226D0 (en) 1988-12-23 1988-12-23 Novel compounds

Publications (1)

Publication Number Publication Date
ATE122352T1 true ATE122352T1 (de) 1995-05-15

Family

ID=10649157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89313491T ATE122352T1 (de) 1988-12-23 1989-12-21 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.

Country Status (13)

Country Link
US (1) US5043342A (de)
EP (1) EP0375450B1 (de)
JP (1) JPH02215782A (de)
KR (1) KR900009638A (de)
AT (1) ATE122352T1 (de)
AU (1) AU620957B2 (de)
CA (1) CA2006436A1 (de)
DE (1) DE68922596T2 (de)
DK (1) DK656889A (de)
GB (1) GB8830226D0 (de)
NZ (1) NZ231970A (de)
PT (1) PT92668B (de)
ZA (1) ZA899821B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69026197T2 (de) * 1989-10-07 1997-01-09 Beecham Group Plc Azabizyklische Verbindungen, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
KR100441404B1 (ko) * 2002-01-24 2004-07-23 한국과학기술연구원 신규한 알케닐 아자 두 고리 화합물 및 그 제조방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2658067A (en) * 1953-11-03 Substituted carbamic acdj esters
GB1053085A (de) * 1964-03-26
US3501471A (en) * 1966-09-21 1970-03-17 American Cyanamid Co Novel 2,3-heterocyclic fused quinuclidines,and 3-substituted quinuclidine-2-carboxylate derivatives
US3681363A (en) * 1970-08-20 1972-08-01 Univ Temple Spiro(imidazolidine-4,3{40 -quinuclidine)-2,5-diones
US4038402A (en) * 1974-03-05 1977-07-26 Mikhail Emmanuilovich Kaminka Method of effecting antihistaminic, antiserotonin and antiallergic actions
US3917615A (en) * 1974-04-01 1975-11-04 Searle & Co 1,1-Diaryl-1-oxadiazol-alkylamines
US4203990A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal 2-substituted quinuclidines
GB8314391D0 (en) * 1983-05-24 1983-06-29 Kefalas As Heterocyclic compounds
JPS6191185A (ja) * 1984-10-11 1986-05-09 Sumitomo Seiyaku Kk 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体
US4599344A (en) * 1984-10-31 1986-07-08 Schering A.G. Quinuclidines and quinuclidinium salts as antiarrhythmic agents
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
EP0261763B1 (de) * 1986-06-27 1994-02-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen
ES2053748T3 (es) * 1987-09-10 1994-08-01 Merck Sharp & Dohme Oxazoles y tiazoles para el tratamiento de la demencia senil.
NZ225999A (en) * 1987-09-10 1992-04-28 Merck Sharp & Dohme Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use

Also Published As

Publication number Publication date
EP0375450B1 (de) 1995-05-10
DE68922596D1 (de) 1995-06-14
DK656889D0 (da) 1989-12-21
JPH02215782A (ja) 1990-08-28
ZA899821B (en) 1990-12-28
AU4706489A (en) 1990-06-28
AU620957B2 (en) 1992-02-27
PT92668A (pt) 1990-06-29
CA2006436A1 (en) 1990-06-23
EP0375450A3 (de) 1991-07-31
US5043342A (en) 1991-08-27
DE68922596T2 (de) 1995-09-28
EP0375450A2 (de) 1990-06-27
GB8830226D0 (en) 1989-02-22
PT92668B (pt) 1995-09-12
NZ231970A (en) 1992-01-29
KR900009638A (ko) 1990-07-05
DK656889A (da) 1990-06-24

Similar Documents

Publication Publication Date Title
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
DE69030206T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DK551989A (da) 3-piperidinyl-1,2-benzisoxazoler, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
ES2053748T3 (es) Oxazoles y tiazoles para el tratamiento de la demencia senil.
NO873125L (no) Fremgangsmaate for fremstilling av antibakterielle forbindelser.
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE69403541T2 (de) Lacton-Verbindung und Verfahren zu ihrer Herstellung
KR0165901B1 (en) 4-[(2-BENZOTHIAZOLYL) METHYLAMINO]-Ñß-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINE ETHANOL
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
ATE120369T1 (de) Verwendung stabiler oxapenem-3-carbonsäuren zur herstellung beta-lactamase hemmender arzneimittel.
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
WO1987004435A3 (en) Xanthine compounds
NO933465L (no) Legemidler inneholdende 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, nye 1,5,6,7-tetrahydro-4-indazol-4-on-derivater, og fremgangsmåte for deres fremstilling

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties